Bandyopadhyay Debashis, Chattopadhyay Aindrila, Ghosh Goutam, Datta Asoke G
Department of Life Science and Biotechnology, Jadavpur University, Kolkata-700 032, India.
Curr Med Chem. 2004 Feb;11(3):369-87. doi: 10.2174/0929867043456016.
Heart disease is one of the major health problems of advanced as well as developing countries of the world. Extensive research through the last decade has shown beyond doubt that free radicals, particularly, reactive oxygen species play a cardinal role in the pathogenesis of oxidative myocardial damage with consequential cardiac malfunction. This review presents a comprehensive account of the present day knowledge regarding the oxygen free radicals involved in the genesis of ischemic heart disease, the mechanism(s) of oxidative myocardial damage and the endogenous as well as exogenous antioxidant defense systems. Furthermore, the role of ischemic pre-conditioning, some antioxidants and the ability of some cardioprotective drugs in providing protection against the ischemic myocardial damage are also discussed. The text of the article comes to an end with a commentary on the future research perspective in the concerned area, which throws a light on the development of combinatorial therapeutics in the treatment of ischemic myocardial disease.
心脏病是世界上发达国家和发展中国家面临的主要健康问题之一。过去十年的广泛研究毫无疑问地表明,自由基,尤其是活性氧在氧化心肌损伤及随之而来的心脏功能障碍的发病机制中起着关键作用。本综述全面阐述了目前关于参与缺血性心脏病发生的氧自由基、氧化心肌损伤的机制以及内源性和外源性抗氧化防御系统的知识。此外,还讨论了缺血预处理、一些抗氧化剂的作用以及某些心脏保护药物在预防缺血性心肌损伤方面的能力。文章最后对相关领域的未来研究前景进行了评论,这为缺血性心肌病治疗中联合疗法的发展提供了思路。